Overview and Scope
Tumor ablation therapy devices are minimally invasive devices used in the treatment of tumors, commonly of kidney, liver and lung
Sizing and Forecast
The tumor ablation therapy devices market size has grown rapidly in recent years. It will grow from <b>$0.64 billion in 2023 to $0.74 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. </b> The growth in the historic period can be attributed to cancer incidence, technological advancements, aging population, minimally invasive procedures.
The tumor ablation therapy devices market size is expected to see rapid growth in the next few years. It will grow to <b>$1.27 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. </b> The growth in the forecast period can be attributed to personalized medicine, combination therapies, ai and image-guided ablation, telemedicine and remote consultations, training and education. Major trends in the forecast period include advancements in ablation technologies, imaging guidance, robotic and navigation assistance, immuno-oncology integration, percutaneous and image-guided ablation.
To access more details regarding this report, visit the link:
Segmentation & Regional Insights
The tumor ablation therapy devices market covered in this report is segmented –
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users
<b>North America</b> was the largest region in the tumor ablation therapy devices market in 2023. <b>Asia-Pacific</b> was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of cancer is a key factor driving the growth of the tumor ablation therapy devices market. Cancer is considered to be the second major cause of death, with around 1 in 6 deaths due to cancer worldwide. Tumor ablation is a minimally invasive procedure widely used in the treatment of lung, liver, kidney, and bone tumors. For instance, in 2023, according to the American Cancer Society Inc., a US-based non-profit health group, 1,958,310 new cancer cases are expected to be diagnosed in the US, an increase compared to more than 1,918,030 new cancer cases in 2022. The procedure is an effective method for patients who have failed chemotherapy or radiotherapy, thereby supporting the tumor ablation therapy devices market growth.
Key Industry Players
Major companies operating in the tumor ablation therapy devices market include <b>Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew plc, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation</b>
The tumor ablation therapy devices market report table of contents includes:
1. Executive Summary
2. Tumor Ablation Therapy Devices Market Characteristics
3. Tumor Ablation Therapy Devices Market Trends And Strategies
4. Tumor Ablation Therapy Devices Market – Macro Economic Scenario
5. Global Tumor Ablation Therapy Devices Market Size and Growth
.
.
.
26. South America Tumor Ablation Therapy Devices Market
27. Brazil Tumor Ablation Therapy Devices Market
28. Middle East Tumor Ablation Therapy Devices Market
29. Africa Tumor Ablation Therapy Devices Market
30. Tumor Ablation Therapy Devices Market Competitive Landscape And Company Profiles
Top Major Players:
- Galil Medical Inc
- Misonix Inc
- HealthTronics Inc
- AngioDynamics Inc
- Boston Scientific Corporation
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
